The Department of Health and Social Care is currently consulting on proposed changes to its statutory regulations pharmaceutical price regulation scheme. This is the scheme under which companies operate if they do not belong to the voluntary pharmaceutical price regulation scheme (PPRS), and is designed to safeguard NHS finances by controlling the amount of profit companies are entitled to make on their medicines. Any changes to the statutory regulations are hoped to come into effect on 1 January 2019, to coincide with the new voluntary PPRS rules.
In this consultation, the changes proposed are:
- Setting out the expected annual payment percentages between 2019 and 2021
- Amending the application of the payment percentage with respect to sales of medicines supplied under a contract with a contracting authority based on a framework agreement or supplied under public contracts
- Including all biological medicinal products (including biosimilars) within the scope of health service medicines
The consultation includes potential for substantial increases in payment from current levels, with:
“an option to apply new annual payment percentages of 9.9%, 15.8% and 21.7% for 2019 through to 2021”
Check the status of the consultation, and find out about other opportunities to contribute to consultations.
Find out more about PPRS and the statutory regulations.